Login
$IMVT
$28.88 +$0.71 (2.52%) Close

$IMVT 3 SEC Filings

Filed On Filing
28 Apr 2025 Form 3: Girao Tiago, Chief Financial Officer

No securities owned

28 Apr 2025 Form 3: Bauer Jake, Director

No securities owned

28 Apr 2025 Form 3: Susman Robert Graham, Director

No securities owned

18 Dec 2024 Form 3: Van Tuyl Christopher, Chief Legal Officer

No securities owned

20 Nov 2024 Form 3: Gloria Melanie, Chief Operating Officer

No securities owned

16 Jan 2024 Form 3: Geffner Michael, Chief Medical Officer*

Holds 100,000 shares of Common Stock

19 Apr 2023 Form 3: Stout Jay S, Chief Technology Officer

No securities owned

28 Jan 2022 Form 3: Levine Mark S., Chief Legal Officer

No securities owned

05 Oct 2021 Form 3: Barnett Eva Renee, Chief Financial Officer

No securities owned

10 Jun 2021 Form 3: Macias William L., Chief Medical Officer

No securities owned

14 Jan 2021 Form 3: Jain Rita, Chief Medical Officer

No securities owned

27 Aug 2020 Form 3: Elliott Michael James, Chief Scientific Officer

No securities owned

19 Feb 2020 Form 3: Venker Eric, Director

No securities owned

20 Dec 2019 Form 3: Roivant Sciences Ltd., 10% owner

Holds 485,000 shares of Common Stock, $0.0001 par value per share

20 Dec 2019 Form 3: Zeldin Robert K, Chief Medical Officer

No securities owned

20 Dec 2019 Form 3: Yanchik Connealy Pamela, Chief Financial Officer

No securities owned

20 Dec 2019 Form 3: Torti Frank, Director

No securities owned

20 Dec 2019 Form 3: Salzmann Peter, Director

No securities owned

20 Dec 2019 Form 3: Fromkin Andrew J., Director

No securities owned

20 Dec 2019 Form 3: Potter Myrtle S, Director

No securities owned

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support